|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
19.620 +0.040 (+0.204%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 17,173,030 | 20,963,787 | 9,308,085 | 11,154,609 |
| Net Cash from / (used in) Investing Activities | -- | (944,535) | (3,589,622) | (1,266,962) | (2,202,758) |
| Net Cash from / (used in) Financing Activities | -- | (7,643,970) | (5,693,481) | (14,693,007) | 2,025,854 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 8,584,525 | 11,680,684 | (6,651,884) | 10,977,705 |
| Cash & Cash Equivalents at beginning of period | -- | 55,221,624 | 43,529,428 | 50,178,265 | 39,191,967 |
| Effect of Foreign Exchange Rate Changes | -- | 2,389 | 11,512 | 3,047 | 8,593 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 63,808,538 | 55,221,624 | 43,529,428 | 50,178,265 |
| Remarks: | Real time quote last updated: 04/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,703,875 |
| %Change | -9.759% |
| EPS / (LPS) | RMB 1.190 |
| NBV Per Share (¥) | RMB 24.207 |